Retatrutide – also know as Reta or LY3437943 – is an experimental synthetic peptide currently studied in clinical trials for the management of obesity and diabetes. While the findings on retatrutide are incomplete and it’s not approved for use in Australia, it’s becoming increasingly popular on the peptide black market. Here’s what you need to know about retatrutide, its potential benefits, side effects and risks of buying it online.
What is retatrutide?
Retatrutide is a synthetic peptide classified as a “triple agonist peptide” because it stimulates the receptors for glucose‑dependent insulinotropic polypeptide (GIP), glucagon‑like peptide‑1 (GLP‑1) and glucagon (GCGR).
Other GLP-1 agonists like semaglutide (known by its brand names Ozempic and Wegovy) only target the GLP-1 receptor.
Results of a Phase 3 trial showed retatrutide use resulted in significant weight loss for people with obesity. Over 20 months, participants on the highest dose (12 mg) lost an average 28% of body weight, with nearly half achieving over 30% weight loss. While the lower 4 mg dose delivered a 20% reduction with fewer side effects. In previous Phase 2 clinical trials, participants reported an average weight loss of about 22.8% (with an 8mg dose) and 24.2% (with 12mg) after retatrutide for 11 months.
Next steps will be for the drug company to submit the trial data to regulators (like the Food and Drug Administration (FDA) in the US and the Therapeutic Goods Administration (TGA) in Australia) for review. If approved, the drug can be commercially manufactured and prescribed to patients. There’s also typically ongoing Phase 4 monitoring after launch to track long-term safety and effectiveness in the broader population.
What are peptides?
Peptides are short chains of amino acids, the building blocks of proteins, found in every cell and involved in many essential body processes. Some peptides act as hormones that regulate immunity, growth and repair, and how we use and store energy. Many medicines are synthetic (lab‑made) peptides that copy or modify natural hormones, for example, insulin for diabetes and semaglutide for diabetes and obesity. There are other synthetic peptides that have not been well tested, often because early studies found they were not effective or are potentially toxic.
How does retatrutide work?
Retatrutide is a once-weekly injectable drug. By activating GLP‑1 and GIP receptors, retatrutide increases glucose‑dependent insulin secretion, slows gastric emptying and reduces appetite. This leads to lower blood glucose and reduced food intake. And by activating the glucagon receptor, it modestly increases energy expenditure and promotes fat oxidation.
What are the side effects of retatrutide?
In clinical trials, retatrutide side effects included gastrointestinal problems like nausea, diarrhea, vomiting and constipation. However, we still don’t know the long-term safety and risks of the drug as research is ongoing.
If you’re buying retatrutide online or from someone at the gym, you don’t know what you’re getting. Doses and ingredients could be different to what’s on the label, and there’s risk of contamination. The TGA released a safety alert in April 2026 stating it was concerned about an increase in the importation and supply of unapproved peptides, which were a “safety risk”. “These products have not been evaluated for safety, quality or effectiveness by the TGA,” the alert said.
The TGA said it has been alerted to severe allergic reactions that have led to hospitalisation, severe inflammation, full-body intense itching, palpitations, pain, insomnia, blurred vision and musculoskeletal injuries as a result of using retatrutide. A case study of a 32-year-old man who used Retatrutide he purchased online reported severe diarrhea that hospitalised him.
Is retatrutide legal in Australia?
Retatrutide is not approved for therapeutic use by the TGA or any other international regulatory agency.
If you’re interested in retatrutide, chat to your doctor. You can ask about enrolling in a registered clinical trial rather than trying to source it yourself.
People also ask
Is retatrutide the same as Ozempic?
No. Retatrutide and Ozempic are different drugs, even though they’re both weekly peptide injections that help with weight and blood sugar. Retatrutide is an experimental “triple agonist” that activates three receptors at once. Ozempic is the brand name for semaglutide, an approved GLP‑1 receptor agonist that targets only the GLP‑1 receptor.
Can I buy retatrutide in Australia?
No. You cannot currently buy legitimate, prescription retatrutide for personal use in Australia. It is still an unapproved investigational drug only available through clinical trials. Products sold online as “retatrutide” for “research” are unapproved.
When will retatrutide be available in Australia?
Even if the drug is approved soon, it’ll still be a couple of years before retatrutide is available in Australia.
